Evaluating Metabolite-Related DNA Oxidation and Adduct Damage from Aryl Amines Using a Microfluidic ECL Array

Overview

Journal Anal Chem

Specialty Chemistry

Date 2017 Oct 31

PMID 29083162

Citations 4

Authors

Itti Bist

Snehasis Bhakta

Di Jiang

Tia E Keyes

Aaron Martin

Robert J Forster

James F Rusling

Affiliations

Soon will be listed here.

Abstract

Damage to DNA from the metabolites of drugs and pollutants constitutes a major human toxicity pathway known as genotoxicity. Metabolites can react with metal ions and NADPH to oxidize DNA or participate in S2 reactions to form covalently linked adducts with DNA bases. Guanines are the main DNA oxidation sites, and 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG) is the initial product. Here we describe a novel electrochemiluminescent (ECL) microwell array that produces metabolites from test compounds and measures relative rates of DNA oxidation and DNA adduct damage. In this new array, films of DNA, metabolic enzymes, and an ECL metallopolymer or complex assembled in microwells on a pyrolytic graphite wafer are housed in dual microfluidic chambers. As reactant solution passes over the wells, metabolites form and can react with DNA in the films to form DNA adducts. These adducts are detected by ECL from a RuPVP polymer that uses DNA as a coreactant. Aryl amines also combine with Cu and NADPH to form reactive oxygen species (ROS) that oxidize DNA. The resulting 8-oxodG was detected selectively by ECL-generating bis(2,2'-bipyridine)-(4-(1,10-phenanthrolin-6-yl)-benzoic acid)Os(II). DNA/enzyme films on magnetic beads were oxidized similarly, and 8-oxodG determined by LC/MS/MS enabled array standardization. The array limit of detection for oxidation was 720 8-oxodG per 10 nucleobases. For a series of aryl amines, metabolite-generated DNA oxidation and adduct formation turnover rates from the array correlated very well with rodent 1/TD and Comet assay results.

Citing Articles

Highly sensitive detection of MMP-2 using an electrochemiluminescent biosensor enhanced by ladder-branch hybridization chain reaction.

Gong Y, Zhang J, Xi Y, Xie Y, Jian D, Jian D Mikrochim Acta. 2024; 191(12):742.

PMID: 39535619 DOI: 10.1007/s00604-024-06761-y.

Confined Electrochemiluminescence Generation at Ultra-High-Density Gold Microwell Electrodes.

Ding J, Zhou P, Guo W, Su B Front Chem. 2021; 8:630246.

PMID: 33575249 PMC: 7870482. DOI: 10.3389/fchem.2020.630246.

Metabolites of Tobacco- and E-Cigarette-Related Nitrosamines Can Drive Cu-Mediated DNA Oxidation.

Kankanamage R, Ghosh A, Jiang D, Gkika K, Keyes T, Achola L Chem Res Toxicol. 2020; 33(8):2072-2086.

PMID: 32672941 PMC: 7510339. DOI: 10.1021/acs.chemrestox.0c00027.

Organ-Specific Screening for Protein Damage Using Magnetic Bead Bioreactors and LC-MS/MS.

Jiang D, Shen M, Ahiadu B, Rusling J Anal Chem. 2020; 92(7):5337-5345.

PMID: 32176468 PMC: 7509849. DOI: 10.1021/acs.analchem.9b05871.

References

Fischer V, Mason R . Formation of iminoxyl and nitroxide free radicals from nitrosonaphthols: an electron spin resonance study. Chem Biol Interact. 1986; 57(2):129-42. DOI: 10.1016/0009-2797(86)90033-5. View

Hvastkovs E, Schenkman J, Rusling J . Metabolic toxicity screening using electrochemiluminescence arrays coupled with enzyme-DNA biocolloid reactors and liquid chromatography-mass spectrometry. Annu Rev Anal Chem (Palo Alto Calif). 2012; 5:79-105. PMC: 3399491. DOI: 10.1146/annurev.anchem.111808.073659. View

Kadlubar F, Unruh L, Beland F, Straub K, Evans F . In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine. Carcinogenesis. 2012; 1(2):139-50. DOI: 10.1093/carcin/1.2.139. View

Plewa M, Wagner E, Yu T, Anderson D . Genotoxicity of m-phenylenediamine and 2-aminofluorene in Salmonella typhimurium and human lymphocytes with and without plant activation. Environ Mol Mutagen. 1995; 26(2):171-7. DOI: 10.1002/em.2850260211. View

Naiman K, Dracinsky M, Hodek P, Martinkova M, Schmeiser H, Frei E . Formation, persistence, and identification of DNA adducts formed by the carcinogenic environmental pollutant o-anisidine in rats. Toxicol Sci. 2012; 127(2):348-59. DOI: 10.1093/toxsci/kfs104. View

Nassar A, Kamel A, Clarimont C . Improving the decision-making process in structural modification of drug candidates: reducing toxicity. Drug Discov Today. 2004; 9(24):1055-64. DOI: 10.1016/S1359-6446(04)03297-0. View

Takahashi N, Fischer V, Schreiber J, Mason R . An ESR study of nonenzymatic reactions of nitroso compounds with biological reducing agents. Free Radic Res Commun. 1988; 4(6):351-8. DOI: 10.3109/10715768809066903. View

Murata M, Tamura A, Tada M, Kawanishi S . Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl. Free Radic Biol Med. 2001; 30(7):765-73. DOI: 10.1016/s0891-5849(01)00463-4. View

Farmer P, Singh R . Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens. Mutat Res. 2008; 659(1-2):68-76. DOI: 10.1016/j.mrrev.2008.03.006. View

10.

Kim D, Guengerich F . Cytochrome P450 activation of arylamines and heterocyclic amines. Annu Rev Pharmacol Toxicol. 2005; 45:27-49. DOI: 10.1146/annurev.pharmtox.45.120403.100010. View

11.

Murata M, Kawanishi S . Mechanisms of oxidative DNA damage induced by carcinogenic arylamines. Front Biosci (Landmark Ed). 2011; 16(3):1132-43. DOI: 10.2741/3739. View

12.

Farmer P, Brown K, Tompkins E, Emms V, Jones D, Singh R . DNA adducts: mass spectrometry methods and future prospects. Toxicol Appl Pharmacol. 2005; 207(2 Suppl):293-301. DOI: 10.1016/j.taap.2004.12.020. View

13.

Wasalathanthri D, Faria R, Malla S, Joshi A, Schenkman J, Rusling J . Screening reactive metabolites bioactivated by multiple enzyme pathways using a multiplexed microfluidic system. Analyst. 2012; 138(1):171-8. PMC: 3509269. DOI: 10.1039/c2an35993f. View

14.

Ohnishi S, Murata M, Kawanishi S . Oxidative DNA damage induced by a metabolite of 2-naphthylamine, a smoking-related bladder carcinogen. Jpn J Cancer Res. 2002; 93(7):736-43. PMC: 5927071. DOI: 10.1111/j.1349-7006.2002.tb01314.x. View

15.

Pan S, Zhao L, Schenkman J, Rusling J . Evaluation of electrochemiluminescent metabolic toxicity screening arrays using a multiple compound set. Anal Chem. 2011; 83(7):2754-60. PMC: 3069143. DOI: 10.1021/ac200050n. View

16.

Hvastkovs E, Rusling J . State-of-the-Art Metabolic Toxicity Screening and Pathway Evaluation. Anal Chem. 2016; 88(9):4584-99. PMC: 4862375. DOI: 10.1021/acs.analchem.5b04772. View

17.

Stiborova M, Miksanova M, Sulc M, Rydlova H, Schmeiser H, Frei E . Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine. Int J Cancer. 2005; 116(5):667-78. DOI: 10.1002/ijc.21122. View

18.

Ohkuma Y, Kawanishi S . Oxidative DNA damage induced by a metabolite of carcinogenic o-anisidine: enhancement of DNA damage and alteration in its sequence specificity by superoxide dismutase. Arch Biochem Biophys. 2001; 389(1):49-56. DOI: 10.1006/abbi.2001.2302. View

19.

Olive P, Banath J, Durand R . Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J Natl Cancer Inst. 1990; 82(9):779-83. DOI: 10.1093/jnci/82.9.779. View

20.

Park B, Boobis A, Clarke S, Goldring C, Jones D, Kenna J . Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov. 2011; 10(4):292-306. DOI: 10.1038/nrd3408. View